Siemens and Dräger are expanding their partnership

Drägerwerk AGDräger acquires 10 percent of Siemens AG shares in its Joint Venture Dräger Medical AG & Co. KG for a sales price of approximately 110 million EUR and increases its stake to 75 percent. At the same time, Siemens AG waves the sales option of its shares originally agreed in the Joint Venture contract and retains its 25 percent holding in the Dräger Medical Group. In addition, Siemens AG plans to purchase 2.5 percent of the Drägerwerk AG, probably in the form of common stock to be issued in the future.

"With an investment in Drägerwerk AG, we document that we want to intensify and continue our partnership," emphasizes Erich R. Reinhardt, member of the Executive Board of Siemens AG and CEO and President of Siemens Medical Solutions. "We have reached an excellent competitive position and are growing faster than the market," added Stefan Dräger, Chairman of Drägerwerk AG. Both companies have contributed to the development of Dräger Medical into one of the leading international manufacturers of medical therapy systems.

In 2003, Drägerwerk AG and Siemens AG founded the Joint Venture Dräger Medical AG & Co. KG, Lübeck. For fiscal year 2006, the total number of employees was at approximately 6,000, and sales of approx. 1.2 billion EUR and an EBIT of approximately 110 million EUR is expected.

Drägerwerk AG is an international leader in the markets for medical and safety technology. In 2005, this technology group generated sales of €1,630.8 million. Founded in 1889, Dräger, Lübeck, nowadays employs around 9,700 people in more than 190 countries, hereof more than 50 percent outside of Germany. The Dräger Medical subgroup offers products and services plus integrated system solutions along the entire patient process chain in the CareAreas™ emergency care, perioperative care, critical and perinatal care, as well as home care. The Dräger Safety subgroup's portfolio covers products and system solutions for holistic hazard management: gas detection, personal and property protection products including a wide variety of services. For further information, visit www.draeger.com.

Most Popular Now

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

To be Happier, Take a Vacation... from Y…

Today, nearly every American - 91% - owns a cellphone that can access the internet, according to the Pew Research Center. In 2011, only about one-third did. Another study finds...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI Revolutionizes Glaucoma Care

Imagine walking into a supermarket, train station, or shopping mall and having your eyes screened for glaucoma within seconds - no appointment needed. With the AI-based Glaucoma Screening (AI-GS) network...

North Cumbria Integrated Care Signs 10-Y…

North Cumbria Integrated Care NHS Foundation Trust (NCIC) has signed a long-term agreement for use of the Alcidion Miya Precision platform, to provide an electronic patient record (EPR) for the...

AI Accelerates Discovery of Neurodevelop…

Researchers have developed an artificial intelligence (AI) approach that accelerates the identification of genes that contribute to neurodevelopmental conditions such as autism spectrum disorder, epilepsy and developmental delay. This new...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...